Hemant Surgical Industries (BOM:543916) Other Stockholders Equity: ₹1,246 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543916 Hemant Surgical Industries Ltd BOM:543916
77 GF Score
Price ₹370.95
GF Value ₹338.27
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Hemant Surgical Industries Other Stockholders Equity?

Hemant Surgical Industries BOM:543916 +0.38% 77 Other Stockholders Equity is ₹1,246 Mil as of Mar. 2026. GuruFocus rates BOM:543916 with a GF Score™ of 77/100 and a GF Value™ of ₹338.27 (Fairly Valued). The stock has 3 warning signs investors should review.

Hemant Surgical Industries's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹1,246 Mil.

Hemant Surgical Industries's quarterly Other Stockholders Equity increased from Mar. 2025 (₹338 Mil) to Sep. 2025 (₹1,101 Mil) and increased from Sep. 2025 (₹1,101 Mil) to Mar. 2026 (₹1,246 Mil).

Hemant Surgical Industries's annual Other Stockholders Equity increased from Mar. 2024 (₹255 Mil) to Mar. 2025 (₹338 Mil) and increased from Mar. 2025 (₹338 Mil) to Mar. 2026 (₹1,246 Mil).

Hemant Surgical Industries Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Hemant Surgical Industries's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemant Surgical Industries Other Stockholders Equity Chart

Hemant Surgical Industries Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial 111.48 156.77 254.77 337.91 1,246.06

Hemant Surgical Industries Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 254.77 476.01 337.91 1,101.10 1,246.06
BOM:543916
77GF Score
Hemant Surgical Industries Ltd BOM:543916
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hemant Surgical Industries Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹1,246 Mil mean?
Hemant Surgical Industries (BOM:543916) has a Other Stockholders Equity of ₹1,246 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hemant Surgical Industries and its competitors.
Is Hemant Surgical Industries' Other Stockholders Equity too high?
Hemant Surgical Industries' current Other Stockholders Equity is ₹1,246 Mil. Overall, Hemant Surgical Industries has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' Other Stockholders Equity compare to ABT and SYK?
Hemant Surgical Industries' Other Stockholders Equity of ₹1,246 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Hemant Surgical Industries and its competitors. Hemant Surgical Industries's current Other Stockholders Equity is ₹1,246 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Fairly Valued. The stock's GF Value™ is ₹338.27, compared to a current price of ₹370.95 — trading 9.7% above its estimated fair value. The current Other Stockholders Equity is ₹1,246 Mil. Hemant Surgical Industries' overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current Other Stockholders Equity is ₹1,246 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?

Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued. The current stock price of ₹370.95 is trading 9.7% above its estimated GF Value™ of ₹338.27. GuruFocus considers Hemant Surgical Industries to be Fairly Valued.

Key valuation signals for BOM:543916:

  • Other Stockholders Equity: ₹1,246 Mil
  • GF Value™: ₹338.27 vs. price of ₹370.95 (9.7% above fair value)
  • GF Score™: 77/100 with 3 warning signs

No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hemant Surgical Industries Business Description

Address J.S.D. Road, 502, 5th Floor, Ecstasy Business Park, Co-Op Society Limited, Mulund West, Mumbai, MH, IND, 400 080
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
77GF Score

Get the complete analysis for BOM:543916

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹370.95
Price
₹338.27
GF Value